SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 167.62 |
| Enterprise Value ($M) | 141.20 |
| Book Value ($M) | -44.86 |
| Book Value / Share | -0.30 |
| Price / Book | -3.74 |
| NCAV ($M) | -228.05 |
| NCAV / Share | -1.51 |
| Price / NCAV | -0.74 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.67 |
| Return on Assets (ROA) | -0.42 |
| Return on Equity (ROE) | n/a |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.48 |
| Current Ratio | 1.78 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 175.41 |
| Assets | 358.60 |
| Liabilities | 403.46 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 126.33 |
| Operating Income | -107.98 |
| Net Income | -113.72 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -117.35 |
| Cash from Investing | 10.58 |
| Cash from Financing | 71.70 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | BlackRock Inc. | 4.50 | -7.00 | |
| 13G/A | Janus Henderson Group Plc | 0.00 | -100.00 | |
| 13G/A | Fmr Llc | 15.00 | 3.74 | |
| 13G/A | Federated Hermes, Inc. | 4.04 | -55.00 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 1,296,411 | 4,280,112 | 30.29 | |
| 836,201 | 3,043,988 | 27.47 | |
| 2,138,702 | 970,932 | 220.27 | |
| 4,235,902 | 997,114 | 424.82 | |
| 2,988,314 | 730,633 | 409.00 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| LVTX – LAVA Therapeutics N.V. | LXRX – Lexicon Pharmaceuticals, Inc. |
| LYEL – Lyell Immunopharma, Inc. | MDGL – Madrigal Pharmaceuticals, Inc. |
| ME – 23andMe Holding Co. |
Financial data and stock pages provided by
Fintel.io